Precigen, Inc.
PGENNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.56B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.04$8.98
- Volume (live)
- -
- Avg. volume (3M)
- 5.34M
Precigen (PGEN) Stock Price & Financial Analysis
Precigen Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.15 - $6.38 |
|---|---|
| 52-Week High | $8.98 |
| 52-Week Low | $3.04 |
| Open | $6.35 |
| Volume (last close) | 4.35M |
| Average Volume (3M) | 5.34M |
| Revenue (TTM) | 85.72M |
|---|---|
| Net Income (TTM) | -157.71M |
| Free Cash Flow (TTM) | -115.83M |
| EPS (TTM) | −$0.47 |
| Profit Margin | -183.98% |
| Operating Margin | -46.08% |
| Return on Equity (ROE) | -361.91% |
| Debt to Equity | 2.18 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.56B |
|---|---|
| Shares Outstanding | 413.69M |
| Price to Sales (P/S) | 29.87 |
| Price to Book (P/B) | 58.76 |
| EV/EBITDA | -18.78 |
| 50-Day MA | $7.28 |
|---|---|
| 200-Day MA | $5.19 |
| 1-Year Change | +50.35% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Precigen at a Glance
As of the Oct 23, 2026 close, Precigen (PGEN) has a market capitalization of $2.56B. The stock trades at 29.9× sales. Over the trailing twelve months it lost $157.71M on revenue of $85.72M and burned $115.83M of free cash flow. Revenue grew 1875.0% year over year.
As of its latest reported balance sheet, it holds $16.33M in cash and securities against $94.94M of debt, a net debt position of $78.61M.
Precigen does not currently pay a dividend.
The share price is up 50.4% over the past year. At $6.19 (the Oct 23, 2026 close) it sits within its 52-week range of $3.04 to $8.98, above its 200-day moving average of $5.19.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Precigen
What is the current stock price for PGEN?
As of the Oct 23, 2026 close, PGEN stock trades at $6.19. The 52-week range is $3.04–$8.98, with a day range of $6.15–$6.38.
What is the P/E ratio for PGEN?
The P/E ratio (Price-to-Earnings) for PGEN is shown in the Key Statistics section. This valuation metric helps compare Precigen, Inc. to industry peers.
Does PGEN pay dividends?
Precigen does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PGEN?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for PGEN is Buy.
What is the market cap of PGEN?
As of the Oct 23, 2026 close, Precigen's market capitalization is $2.56B, classifying it as a mid-cap company. Precigen operates in the Healthcare sector within the Biotechnology industry.